November 15, 2019—Yesterday, Abir Sen, Gravie CEO & Co-founder, sat on Vator’s Invent Health panel, “Healthcare Insurance Big Picture” at HP headquarters in Palo Alto, California.
Vator is a community-based professional group focused on the funding and building of emerging technologies for startups. Invent Health is a series of events Vator put on throughout the year covering various med tech topics, and the theme of yesterday’s event was the future of health insurance.
On the “Healthcare Insurance Big Picture” panel, Sen was joined by other big names in the arena, including Bind Benefits co-founder, Shawn Wagoner, the CEO of Sutter Health/Aetna, Steven Wiggington, a partner at Omers Ventures, Michael Yang, and head of AI and emerging tech at Anthem, Jonna Kurucz. The panel was moderated by HP’s global medical director, Archana Dubey, M.D. and Vator founder and CEO Bambi Francisco.
The discussion lasted over 90 minutes and covered insights into the major problems with the health insurance industry and innovative ideas surrounding ways to lower costs, ways to empower individuals to be better consumers of health services, and the impact consumer choice could play in reinventing the industry. Since 2013, Gravie has been at the forefront of the consumer-focused healthcare movement.
As a pioneer in the defined contribution benefits space, Gravie was founded on the belief that consumer choice when it comes to health benefits is key to providing better access to better overall care.
“The health insurance supply chain is broken. At Gravie, we’re changing this. We’re aligning everyone’s incentives with that of the consumer by giving the consumer—the end user—the purchasing power.” – Abir Sen.
The event wrapped up with an influx of comments and questions from the audience. After four hours of discussion and presentations, Invent Health attendees can agree that there is no shortage of innovative ideas and emerging technologies in the works, and the healthcare and health insurance industries will likely be drastically different in the not too distant future.